Nitrosamine Impurities; What’s the Impact on IMPs
October 13, 2020
N-nitrosamines are a regulatory and industry hot topic and whilst the focus has been on marketed products rather than development portfolios, there is an impact on investigational medicinal product development and manufacture. This webinar, led by Paul Cummings, will discuss nitrosamine impurities including key considerations when developing an IMP, the risks of delaying a formal risk assessment and more.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
Brooklands New Media’s Publication On NSF’s Global Animal Wellness Standards (GAWS) Not Endorsed by NSF
November 25, 2024NSF is aware that a firm called Brooklands New Media plans to publish a book to mark the 5th anniversary of NSF Global Animal Wellness Standards (GAWS).
Read the Story
NSF Announces Participation in Sustainable Foods 2025, CNBC Docuseries
November 18, 2024In January 2025, Lisa Spicka de Bevacqua, NSF’s Director of Sustainability Consulting, will speak at the Sustainable Foods 2025 International Conference and Exhibition in London, UK.
Read the Story
NSF CEO Pedro Sancha Joins TIC Council's TIC Talks
November 7, 2024Pedro Sancha reflected on his career journey, leadership approach and insights into the future of public health and the TIC sector.
Read the Story
Look for the Butterfly and Celebrate Non-GMO Month this October
October 22, 2024NSF celebrates Non-GMO Month with Watkins and Mary's Whole Life, showcasing NSF certified products!
Read the Story